Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
Insilico and Takeda test whether Pharma.AI can convert discovery speed into…
Merck KGaA Bio-Techne Deal | Lucid Diligence Brief
Merck KGaA’s US$11.3bn Bio-Techne acquisition tests workflow depth, integration…
DermaSensor AI dermatology devices | Lucid Diligence Brief
AI dermatology devices are advancing beyond validation studies as DermaSensor…
Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief
Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…
Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief
Merck and Protillion partner on AI protein design. Assess milestones, platform…
Intravacc and SynphaBase Conjugate Vaccine Partnership | Lucid Diligence Brief
Can Intravacc and SynphaBase create a streamlined synthetic glycan-to-GMP…
GNI Group Acquires Ayumi Pharmaceutical | Lucid Diligence Brief
GNI Group’s Ayumi acquisition tests Japan commercial scale, Calonal durability,…
Vida Health and Instacart Health Partner on Fresh Funds | Lucid Diligence Brief
Vida Health’s Instacart Health partnership tests whether grocery stipends can…
Haisco Lilly Collaboration | Lucid Diligence Brief
Haisco’s Lilly Deal Tests China-Originated Small-Molecule Discovery…
Secretome STM-01 Duchenne Cardiomyopathy | Lucid Diligence Brief
Secretome’s STM-01 faces Duchenne cardiomyopathy endpoint, CMC, and regulatory…
Lucid Diligence Brief: Unio Health Partners and Thesis Care partnership
Lucid Diligence Brief: Unio Health Partners and Thesis Care’s AI clinical teams…
Lucid Diligence Brief: Insilico and Human Longevity collaboration
Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…